Pregnancy app aims to get Moms-to-Be moving
NCT ID NCT03688087
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app called 'Bouge' to see if it could help pregnant women walk more each day. 250 pregnant women used either the Bouge app or a placebo app starting at 15 weeks. The goal was to increase daily steps by 2,000. Researchers also looked at sleep, well-being, and back pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- smartphone application 'Bouge'
- What this could lead to
- If it works, this could offer a simple, app-based way to help pregnant women stay active and improve their well-being.
- What could go wrong
- This is a completed study, but the app may not lead to lasting changes in activity. Results may not apply to all pregnant women, especially those with complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOBILE HEALTH APPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH de Morlaix
Morlaix, 29672, France
-
CHRU de Brest
Brest, 29609, France
-
Chic Quimper
Quimper, 29000, France
-
Clinique KERAUDREN
Brest, 29200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ten-minute classroom workouts may boost student mental health
- Teaching teens to navigate transit may boost activity and heart health
- Online exercise program aims to revive postpartum sexual health
- Can Early-Life exposures shape lifelong health? a 1000-Family study aims to find out
- Spa therapy plus education: a new recipe for knee osteoarthritis?
- Bollywood dance and fitness trackers: a new weapon against breast cancer?